MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation

Leukemia

Volumn 31, Issue 12, 2017, Pages 2732-2741

  Stickel, N ^a,b,c   Hanke, K ^a,c   Marschner, D ^a   Prinz, G ^a   Kohler M ^b,c,d   Melchinger, W ^a   Pfeifer, D ^a   Schmitt Graeff, A ^e   Brummer, T ^b,d   Heine, A ^f   Brossart, P ^f   Wolf, D ^f   von Bubnoff, N ^a,g   Finke, J ^a   Duyster, J ^a   Ferrara, J ^h   Salzer, U ^e   Zeiser, R ^a,b,g  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c ALU Freiburg   (Germany)

^d ALU Freiburg   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f UNIVERSITY HOSPITAL BONN   (Germany)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CYTOKINE; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICRORNA 146A; RUXOLITINIB; TRANSACTIVATOR PROTEIN; JANUS KINASE; MICRORNA; MIRN146 MICRORNA, MOUSE; STAT PROTEIN;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CASE CONTROL STUDY; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAK-STAT SIGNALING; MONOCYTE; PHASE 1 CLINICAL TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL TRANSPLANTATION; ANIMAL; GENE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MOUSE; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

ANIMALS; CASE-CONTROL STUDIES; DENDRITIC CELLS; GENE EXPRESSION; GENES, MHC CLASS II; GRAFT VS HOST DISEASE; JANUS KINASES; MICE; MICE, KNOCKOUT; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; STEM CELL TRANSPLANTATION;

EID: 85031116617     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2017.137     Document Type: Article

References (26)

1. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769–773. DOI: 10.1038/nature03315
2. Stickel N, Prinz G, Pfeifer D, Hasselblatt P, Schmitt-Graeff A, Follo M et al. miR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD. Blood 2014; 124: 2586–2595. DOI: 10.1182/blood-2014-04-569046
3. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481–12486. DOI: 10.1073/pnas.0605298103
4. Nahid MA, Pauley KM, Satoh M, Chan EK. miR-146a is critical for endotoxin-induced tolerance: Implication in innate immunity. J Biol Chem 2009; 284: 34590–34599. DOI: 10.1074/jbc.M109.056317
5. Labbaye C, Testa U. The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer. J Hematol Oncol 2012; 5: 13. DOI: 10.1186/1756-8722-5-13
6. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 2008; 105: 7269–7274. DOI: 10.1073/pnas.0802682105
7. Gazouli M, Papaconstantinou I, Stamatis K, Vaiopoulou A, Zeglinas C, Vassiliou I et al. Association study of genetic variants in miRNAs in patients with inflammatory bowel disease: preliminary results. Dig Dis Sci 2013; 58: 2324–2328. DOI: 10.1007/s10620-013-2640-y
8. Yang Y, Zhang K, Zhou R. Meta-analysis of pre-miRNA polymorphisms association with susceptibility to autoimmune diseases. Immunol Invest 2014; 43: 13–27. DOI: 10.3109/08820139.2013.822389
9. Zeiser R, Burchert A, Lengerke C, Verbeek M, Maas-Bauer K, Metzelder SK et al. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multi-center survey. Leukemia 2015; 29: 2062–2068. DOI: 10.1038/leu.2015.212
10. Lofgren SE, Frostegard J, Truedsson L, Pons-Estel BA, D'Alfonso S, Witte T et al. Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. Genes Immun 2012; 13: 268–274. DOI: 10.1038/gene.2011.84
11. Bogunovic M, Ginhoux F, Wagers A, Loubeau M, Isola LM, Lubrano L et al. Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. J Exp Med 2006; 203: 2627–2638. DOI: 10.1084/jem.20060667
12. Young JW, Merad M, Hart DN. Dendritic cells in transplantation and immune-based therapies. Biol Blood Marrow Transplant 2007; 13: 23–32. DOI: 10.1016/j.bbmt.2006.10.023
13. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412–415. DOI: 10.1126/science.285.5426.412
14. Koyama M, Kuns RD, Olver SD, Raffelt NC, Wilson YA, Don AL et al. Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease. Nat Med 2012; 18: 135–142. DOI: 10.1038/nm.2597
15. Cooke KR, Gerbitz A, Crawford JM, Teshima T, Hill GR, Tesolin A et al. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 2001; 107: 1581–1589. DOI: 10.1172/JCI12156
16. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545–15550. DOI: 10.1073/pnas.0506580102
17. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 1994; 265: 106–109. DOI: 10.1126/science.8016643
18. Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, Waldman JW et al. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 1998; 187: 675–683. DOI: 10.1084/jem.187.5.675
19. Martin P, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C et al. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2012; 18: 1150–1163. DOI: 10.1016/j.bbmt.2012.04.005
20. Jurkin J, Schichl YM, Koeffel R, Bauer T, Richter S, Konradi S et al. miR-146a is differentially expressed by myeloid dendritic cell subsets and desensitizes cells to TLR2-dependent activation. J Immunol 2010; 184: 4955–4965. DOI: 10.4049/jimmunol.0903021
21. Park H, Huang X, Lu C, Cairo MS, Zhou X. MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins. J Biol Chem 2015; 290: 2831–2841. DOI: 10.1074/jbc.M114.591420
22. Jackson SH, Yu CR, Mahdi RM, Ebong S, Egwuagu CE. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J Immunol 2004; 172: 2307–2315. DOI: 10.4049/jimmunol.172.4.2307
23. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009; 60: 1065–1075. DOI: 10.1002/art.24436
24. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010; 142: 914–929. DOI: 10.1016/j.cell.2010.08.012
25. Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol 2010; 8: 296–307. DOI: 10.1038/nrmicro2321
26. Spoerl S, Mathew NR, Bscheider M, Schmitt-Graeff A, Chen S, Mueller T et al. Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease. Blood 2014; 123: 3832–3842. DOI: 10.1182/blood-2013-12-543736